Condition: Reflex Syncope · Sponsor: Institut d'Investigació Biomèdica de Bellvitge
Reflex syncope is the most common form of syncope. It can lead to injuries and affect quality of life. Nonpharmacological and medical therapies have limited effectiveness. In certain patients, cardiac pacing seem to be beneficial. More recently cardioneuroablation (CNA) has emerged as a novel therapy for reflex syncope. The investigators aim to determine whether CNA is more effective than cardiac pacing at reducing the rate of cardioinhibitory-type reflex syncope.
This description comes directly from the study's public registry record.
Rodolfo San Antonio, MD, PhD · 932607500 · rsanantonio@bellvitgehospital.cat
Always discuss trial participation with your own doctor first.
| Hospital Universitario San Juan de Alicante | Sant Joan d'Alacant, Alicante, Spain | Not Yet Recruiting |
| Hospital Universitari General de Castellón | Castellon, Castellón, Spain | Not Yet Recruiting |
| Hospital Universitario Álvaro Cunqueiro de Vigo | Vigo, Pontevedra, Spain | Not Yet Recruiting |
| Hospital del Mar | Barcelona, Spain | Not Yet Recruiting |
| Hospital de la Santa Creu i Sant Pau | Barcelona, Spain | Not Yet Recruiting |
| Hospital Universitario de Bellvitge | Barcelona, Spain | Recruiting |
| Hospital Universitari Dr. Josep Trueta | Girona, Spain | Not Yet Recruiting |
| Hospital Universitario Nuestra Señora de Candelaria | Santa Cruz de Tenerife, Spain | Not Yet Recruiting |
| Hospital Universitari i Politècnic La Fe | Valencia, Spain | Not Yet Recruiting |
| Hospital Clínico Universitario Lozano Blesa | Zaragoza, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05855603